AMICUS THERAPEUTICS INC FOLD 3 12.15.23
NOTE 3.000%12/1 · US DOMESTIC · CUSIP 03152WAB5
2
institutional holders
+0 vs Q4 2020
$2.8mprincipal reported held*
$4.5mreported value*
1 new
0 added
0 reduced
1 sold out
net sold ≈ $40.4k
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable.
Trends to Q1 2021
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q4 2019 | 2 |
| Q1 2020 | 2 |
| Q2 2020 | 2 |
| Q3 2020 | 2 |
| Q4 2020 | 2 |
| Q1 2021 | 2 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Bought or addedCut or sold out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q1 2020 | 0 | 0 |
| Q2 2020 | 0 | 0 |
| Q3 2020 | 0 | 0 |
| Q4 2020 | 0 | 0 |
| Q1 2021 | 1 | 1 |
Biggest buyers
| Warberg Asset Management LLC | New | +2.8m |
Biggest sellers
| Alberta Investment Management Corp | Sold out | -2.8m |
Holders, Q1 2021
| Manager | Shares | Change |
|---|---|---|
| Warberg Asset Management LLC 2.22% of their portfolio | 2.8m $4.5m | New |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | Unchanged |